CULLIGAN (UK) LIMITED

Financial Health Assessment: CULLIGAN (UK) LIMITED

1. Financial Health Score: B+ (Structural & Compliance Health) / Pending (Financial Metric Health)

Explanation: Based on the available corporate data, Culligan (UK) Limited presents a very strong structural and compliance profile. The company has a robust "heartbeat" evidenced by its 35-year operating history and flawless filing record. However, much like a patient who has left the doctor's office before the blood test results came back, the specific financial vital signs (profitability, liquidity, and solvency) are not visible in this dataset. The score of B+ reflects excellent administrative health and the stability of being backed by a substantial corporate group, though the lack of granular financial metrics means the purely financial grade remains pending.

2. Key Vital Signs

• Corporate Pulse (Age & Status): Active & Mature. Incorporated in 1989, this business has a strong pulse. Surviving over three decades in the competitive "other food services" (water solutions) market shows exceptional resilience and adaptability.
• Compliance Temperature (Filing Status): Normal (37°C). The company is filing its accounts on time (next due Sept 2026) and its confirmation statement is up to date. There are no signs of the regulatory fever that often accompanies companies in distress.
• Genetic Lineage (Corporate Structure & PSCs): Complex DNA. The ownership structure is heavily layered. Entities like Osmosis Buyer Limited, Ash2003 Limited, and Waterlogic Holdings Limited all hold significant control (>75% shares/voting rights). This is typical of private-equity-backed or large corporate group structures, meaning the UK entity's financial health is deeply intertwined with its parent group's circulatory system.
• Organ Function (Directorate): Stable, with recent mild restructuring. Three directors are currently active, with one recent resignation in early 2026. This is often a standard post-acquisition symptom as new parent companies adjust the board, rather than a sign of internal distress.
• Blood Type (Share Capital): £62. The nominal share capital is incredibly low. In a mature, trading company, this usually indicates that the business operates with minimal share capital and relies instead on inter-company loans from its parent companies to fund its operations.

3. Diagnosis

The patient is structurally sound but has recently undergone major corporate surgery. The history of previous names—transitioning from Aquarius to Chiltern Hills Watercoolers, to Angel Springs, to Waterlogic, and finally to Culligan—reads like a medical chart of a business that has grown through successive acquisitions.

The recent rebrand to Culligan (in 2023) aligns the UK entity with the global Culligan brand, following the acquisition of the Waterlogic group. The complex People with Significant Control (PSC) register confirms that this UK entity is a subsidiary within a much larger corporate anatomy. The low share capital (£62) combined with the requirement to file "Full" accounts suggests a business that likely carries significant inter-company debt on its balance sheet. While the UK entity may be profitable operationally, its ultimate financial wellness is highly dependent on the financial health of the wider global group providing its life support (funding).

4. Recommendations

• Request the Full Bloodwork: To truly diagnose financial health, one must look past the corporate overview and examine the full filed accounts at Companies House. Specifically, review the balance sheet for inter-company creditors/debtors and the profit and loss account to ensure the UK entity is generating healthy cash flow rather than just relying on the parent group.
• Monitor Post-Acquisition Integration: Following the rebrand to Culligan and the recent director resignation, keep a close eye on board composition and strategic shifts. Ensure that the UK operations are not being cannibalized for the benefit of the global group at the expense of local financial health.
• Assess Inter-Company Dependency: Given the >75% control by multiple parent entities, it is vital to understand the terms of the inter-company funding. If the parent group experiences a financial "heart attack," the UK subsidiary could see its life support cut off, regardless of its own operational health.